GC Biopharma Corp. (KRX: 006280)
South Korea
· Delayed Price · Currency is KRW 166,700
-2,300 (-1.36%)
Dec 20, 2024, 3:30 PM KST
GC Biopharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -18,855 | -26,632 | 65,453 | 123,212 | 81,049 | -3,638 | Upgrade
|
| Depreciation & Amortization | 79,906 | 75,899 | 65,096 | 55,904 | 48,791 | 46,666 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1,397 | 2,919 | -40,657 | -6,991 | -59,361 | -853 | Upgrade
|
| Asset Writedown & Restructuring Costs | 697 | - | - | - | 8,140 | 17,000 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4,619 | -1,209 | 660 | 333 | -36,673 | 7,043 | Upgrade
|
| Loss (Gain) on Equity Investments | 20,732 | 38,431 | 18,099 | -81,533 | 5,635 | 2,843 | Upgrade
|
| Provision & Write-off of Bad Debts | 903 | 2,789 | 2,246 | 6,980 | 336 | 1,640 | Upgrade
|
| Other Operating Activities | 22,954 | 2,649 | 17,119 | 47,052 | 69,970 | 5,853 | Upgrade
|
| Change in Accounts Receivable | 36,460 | -47,093 | 13,219 | -10,756 | -16,862 | -11,132 | Upgrade
|
| Change in Inventory | -164,842 | -69,234 | 1,721 | -14,919 | -52,086 | -21,983 | Upgrade
|
| Change in Accounts Payable | -1,521 | 22,689 | 4,011 | -16,463 | -3,906 | -5,459 | Upgrade
|
| Change in Other Net Operating Assets | 25,247 | -6,681 | -27,813 | 23,160 | -9,059 | 2,311 | Upgrade
|
| Operating Cash Flow | -1,541 | -5,473 | 119,154 | 125,979 | 35,974 | 40,291 | Upgrade
|
| Operating Cash Flow Growth | - | - | -5.42% | 250.20% | -10.72% | 179.60% | Upgrade
|
| Capital Expenditures | -55,579 | -79,087 | -57,996 | -102,321 | -82,876 | -127,454 | Upgrade
|
| Sale of Property, Plant & Equipment | 839.53 | 1,319 | 1,540 | 565.21 | 236.6 | 2,105 | Upgrade
|
| Cash Acquisitions | - | - | -74,053 | 11,918 | -1,582 | - | Upgrade
|
| Divestitures | 215.15 | - | - | - | - | 3,793 | Upgrade
|
| Sale (Purchase) of Intangibles | -16,746 | -45,914 | -36,694 | -21,143 | -18,345 | -18,969 | Upgrade
|
| Investment in Securities | -25,909 | -25,139 | -31,332 | -30,734 | 24,393 | -35,145 | Upgrade
|
| Other Investing Activities | -1,985 | -1,423 | -723.7 | 10,133 | 107,856 | -2,240 | Upgrade
|
| Investing Cash Flow | -99,564 | -150,243 | -205,259 | -132,077 | 29,684 | -177,910 | Upgrade
|
| Short-Term Debt Issued | - | 1,188,247 | 806,151 | 869,500 | 1,044,670 | 564,343 | Upgrade
|
| Long-Term Debt Issued | - | 5,000 | 30,608 | 209,429 | 23,800 | 121,582 | Upgrade
|
| Total Debt Issued | 1,425,192 | 1,193,247 | 836,759 | 1,078,929 | 1,068,470 | 685,925 | Upgrade
|
| Short-Term Debt Repaid | - | -1,059,800 | -721,740 | -992,600 | -885,603 | -525,271 | Upgrade
|
| Long-Term Debt Repaid | - | -9,419 | -135,590 | -102,423 | -100,486 | -91,539 | Upgrade
|
| Total Debt Repaid | -1,323,343 | -1,069,219 | -857,330 | -1,095,023 | -986,088 | -616,810 | Upgrade
|
| Net Debt Issued (Repaid) | 101,849 | 124,028 | -20,571 | -16,094 | 82,382 | 69,115 | Upgrade
|
| Dividends Paid | -19,532 | -24,825 | -23,985 | -18,511 | -12,719 | -12,378 | Upgrade
|
| Other Financing Activities | 484.41 | 1,308 | 42,075 | -6,665 | 11,325 | 84,069 | Upgrade
|
| Financing Cash Flow | 82,801 | 100,512 | -2,481 | -41,270 | 80,987 | 140,805 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1,330 | -455.39 | 7,891 | 1,141 | -12,818 | -1,360 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - | Upgrade
|
| Net Cash Flow | -19,634 | -55,660 | -80,694 | -46,228 | 133,827 | 1,826 | Upgrade
|
| Free Cash Flow | -57,121 | -84,560 | 61,158 | 23,658 | -46,902 | -87,163 | Upgrade
|
| Free Cash Flow Growth | - | - | 158.51% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -3.47% | -5.20% | 3.57% | 1.54% | -3.12% | -6.42% | Upgrade
|
| Free Cash Flow Per Share | -5004.79 | -7408.97 | 5358.56 | 4681.52 | -4109.46 | -7637.06 | Upgrade
|
| Cash Interest Paid | 36,832 | 24,080 | 19,378 | 13,546 | 9,727 | 7,062 | Upgrade
|
| Cash Income Tax Paid | 2,896 | 19,033 | 37,349 | 18,867 | 8,983 | 17,791 | Upgrade
|
| Levered Free Cash Flow | -76,122 | -166,642 | 52,929 | -10,238 | -57,365 | -90,241 | Upgrade
|
| Unlevered Free Cash Flow | -51,985 | -148,840 | 64,424 | -2,425 | -50,894 | -84,235 | Upgrade
|
| Change in Net Working Capital | 80,363 | 120,933 | -43,575 | -19,057 | 29,830 | 10,534 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.